< Go Back

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients
Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis
OFEV® (nintedanib) Now Available in the United States
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant
IMBRUVICA® (ibrutinib) Supplemental New Drug Application Submitted to the U.S. FDA for Waldenstrom's macroglobulinemia
IonMed Receives CE Mark Clearance for Bioweld1™ Cold Plasma System
Taiho Oncology, Inc. Receives FDA Fast Track Designation for TAS-102 as a Potential Treatment for Refractory Metastatic Colorectal Cancer
Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA® for Waldenstrom's Macroglobulinemia
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults
Pulmonary Fibrosis Foundation Applauds The Food And Drug Administration's (FDA) Prompt Decision To Approve Esbriet® (pirfenidone) And OFEV® (nintedanib) For The Treatment Of Idiopathic Pulmonary Fibrosis
Esbriet® (pirfenidone) receives FDA approval under 'breakthrough status'; Diplomat to distribute
FDA Approves Boehringer Ingelheim's OFEV® (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Konica Minolta Wireless Digital Radiography Solution for Extreme Environments Receives FDA Clearance
FDA Grants Eisai's sNDA for Rufinamide Priority Review as Adjunctive Treatment in Pediatric Patients Ages 1-4 for Seizures Associated with Lennox-Gastaut Syndrome
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg
Aethlon Medical Announces First Treatment of an Ebola Patient
BioLight to Present its IOPtiMate™ System at the Ophthalmology Innovation Summit @ the American Academy of Ophthalmology 2014
FDA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)
FDA Approves VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older
FDA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)
Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug
DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation at the American Society of Anesthesiologists Annual Meeting
InSightec to Share Key Insights and Progress at the 4th Focused Ultrasound International Symposium
Alimera Sciences to Present at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Annual Meeting
Astute Medical And CRG Announce FDA Milestone Under Term Loan Agreement
FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device
Syneron Announces Launch of PicoWay Picosecond Device for Pigmented Lesion Treatment and Tattoo Removal
Nabriva Therapeutics Announces Qualified Infectious Disease Product and Fast Track Status Granted by the US FDA for Lefamulin
Ferring Pharmaceuticals Inc. Receives FDA Approval For New Cranberry Flavor Of PREPOPIK® (Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid)
Manzo Pharmaceuticals gets confirmation that Lacto-Freedom probiotic is a dietary supplement and will not need FDA approval
EYLEA® (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO)
PicoSure® Is FDA-Cleared For Treatment Of Fine Lines And Wrinkles
InSightec Announces HCSC Positive Coverage Decision for its MRgFUS Procedure for Pain Palliation of Bone Cancer Metastases
AbbVie's HUMIRA® (adalimumab) Receives U.S. FDA Approval for Extension of Polyarticular Juvenile Idiopathic Arthritis Indication to Patients Ages 2 and Older
Mylan Launches Generic Combivir®
Elbit Imaging Ltd. Announces That InSightec Announces HCSC Positive Coverage Decision For Its ExAblate Procedure For Pain Palliation Of Bone Cancer Metastases
BioTE's Dr. Donovitz Challenges FDA Panel
B. Braun Receives FDA Approval For New Large-Volume Injection Containers
FDA Grants Fast Track Designation to NKT Therapeutics' NKTT120 for the Treatment of Sickle Cell Disease
Otezla® (apremilast) receives expanded indication; Diplomat to distribute
XTANDI® (enzalutamide) receives expanded approval from FDA for treatment of metastatic castration-resistant prostate cancer
CSL Behring Expands Manufacturing Facility In Kankakee, Illinois To Meet Patients' Growing Needs
ELDOR Spinal Needle (CSEN International Ltd.) - The Perfect Needle for Spinal Anesthesia
Synapse Biomedical Announces the Early Completion of Enrollment in the FDA Post Approval Study for ALS Patients
LapSpace Nears Market Entry with Completion of FIM Surgical Procedures
Par Pharmaceutical Begins Shipment of Generic Exforge®
Luminex Receives FDA Clearance To Add New Clinical Targets And Additional Sample Type For Use With xTAG® Gastrointestinal Pathogen Panel
Occlutech Obtains European CE Approval for its Dedicated Paravalvular Leak Closure Device
Clinical Study Results of LifeBond's LifeSeal™ Surgical Sealant for GI Surgeries Announced at the ESCP's 9th Scientific & Annual Meeting
Alimera Sciences Provides Details On FDA Approval Of ILUVIEN® As The First Long-Term Treatment For Diabetic Macular Edema

< Prev Next >
PR Newswire - United Business Media